Table 3. Cut-off values of total adiponectin level for managing risk of developing MetS according to top five log likelihoods in each survival distribution.
| Rank order | Cut-off value of total adiponectin (μg/ml) | Log likelihood* | AIC* | |
|---|---|---|---|---|
| Weibull distribution | 1 | 6.2 | -161.71 | 339.428 |
| 2 | 6.3 | -162.50 | 341.007 | |
| 3 | 6.1 | -162.57 | 341.146 | |
| 4 | 6.4 | -163.11 | 342.226 | |
| 5 | 6.5 | -163.34 | 342.675 | |
| Exponential distribution | 1 | 6.2 | -163.19 | 340.389 |
| 2 | 6.3 | -163.99 | 341.986 | |
| 3 | 6.1 | -164.11 | 342.210 | |
| 4 | 6.4 | -164.61 | 343.223 | |
| 5 | 6.5 | -164.80 | 343.598 | |
| Gamma distribution | 1 | 6.2 | -161.70 | 341.394 |
| 2 | 6.3 | -162.50 | 342.990 | |
| 3 | 6.1 | -162.52 | 343.039 | |
| 4 | 6.4 | -163.11 | 344.214 | |
| 5 | 6.5 | -163.33 | 344.670 |
Cut-off values were confined to top five log likelihoods in each survival distribution.
* Comparison was made between subjects with total adiponectin level ≤ cut-off value and subjects with total adiponectin level > cut-off value.
Multivariate adjustment was performed for age, BMI, smoking habit, alcohol intake, and regular exercise.
MetS, metabolic syndrome; AIC, Akaike’s information criterion